Device and drug manufacturer
Issues relating to drug shortages, patent use codes and drug labeling (RIN:0910-AG94: FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products) Implementation of the Biologics Price Competition and Innovation Act (BPCIA) relating to biosimilar naming. Issues relating to opiate overdosing
PHA - Pharmacy HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office
BROWN RUDNICK LLP
601 13th Street, NW, 6th Floor, Washington, DC, 20005, US
HENRY W MENN (Min SD & Counsel, Cmte on Vet Affairs (04)) LISA LAYMAN (SPA, Sen Stabenow(05-07)) CHRISTOPHER BOWLIN (Secr for Congr & Intgv Affairs, Dept. Labor 01-02) HENRY W MENN CHRISTOPHER BOWLIN LISA LAYMAN
Min SD & Counsel, Cmte on Vet Affairs (04) SPA, Sen Stabenow(05-07) Secr for Congr & Intgv Affairs, Dept. Labor 01-02